← Open Payments lookup

KRISTINA FODOR: Open Payments

NPI 1104395193 · COLORADO SPGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,669 in 81 payments from 15 companies in 2025. Trend: 2023 $36 · 2024 $696 · 2025 $1,669

Food & beverage: $1,662Consulting: $7
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP14$463
Genentech USA, Inc.14$234
GlaxoSmithKline, LLC.17$196
Novartis Pharmaceuticals Corporation9$181
Takeda Pharmaceuticals U.S.A., Inc.8$154
Amgen Inc.6$145
GENZYME CORPORATION3$81
Grifols USA, LLC2$45
Pharming Healthcare, Inc.2$45
Ionis Pharmaceuticals, Inc.1$33

Products named: TEZSPIRE, Xolair, FASENRA, NUCALA, DUPIXENT, TRELEGY ELLIPTA, CUVITRU, RUCONEST.

Industry payments across CO — which companies pay providers there.